Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score.

Adriano R TonelliAdriano R TonelliMona SelejZachary WatsonRaymond L Benza

Published in: PloS one (2020)

More than half of FC II PAH patients were classified as intermediate/high risk using objective multiparameter assessments. Incorporating objective risk-assessment algorithms into clinical practice may better inform risk assessment and treatment strategies.

Keyphrases

risk assessment
pulmonary arterial hypertension
human health
heavy metals
clinical practice
pulmonary artery
pulmonary hypertension
end stage renal disease
ejection fraction
machine learning
newly diagnosed
emergency department
genome wide
prognostic factors
patient reported outcomes
dna methylation
climate change